PB2655: EVALUATION OF THE EFFICACY AND SAFETY IMMUNOSUPPRESSIVE THERAPY IN PATIENTS WITH ACQUIRED FACTOR VIII AND IX INHIBITOR

Bibliographic Details
Main Authors: Derya Koyun, Güldane Cengiz Seval, Sinem Civrizbozdağ, Muhit Özcan, Pervin Topçuoğlu
Format: Article
Language:English
Published: Wiley 2023-08-01
Series:HemaSphere
Online Access:http://journals.lww.com/10.1097/01.HS9.0000977304.57128.06
_version_ 1797281720375967744
author Derya Koyun
Güldane Cengiz Seval
Sinem Civrizbozdağ
Muhit Özcan
Pervin Topçuoğlu
author_facet Derya Koyun
Güldane Cengiz Seval
Sinem Civrizbozdağ
Muhit Özcan
Pervin Topçuoğlu
author_sort Derya Koyun
collection DOAJ
first_indexed 2024-03-07T17:01:31Z
format Article
id doaj.art-fc2f9781e38c461bb22289f919454723
institution Directory Open Access Journal
issn 2572-9241
language English
last_indexed 2024-03-07T17:01:31Z
publishDate 2023-08-01
publisher Wiley
record_format Article
series HemaSphere
spelling doaj.art-fc2f9781e38c461bb22289f9194547232024-03-03T03:24:11ZengWileyHemaSphere2572-92412023-08-017e571280610.1097/01.HS9.0000977304.57128.06202308003-02500PB2655: EVALUATION OF THE EFFICACY AND SAFETY IMMUNOSUPPRESSIVE THERAPY IN PATIENTS WITH ACQUIRED FACTOR VIII AND IX INHIBITORDerya Koyun0Güldane Cengiz Seval1Sinem Civrizbozdağ2Muhit Özcan3Pervin Topçuoğlu41 Ankara University School of Medicine, Hematology Department, Ankara, Turkey2 Ankara University School of Medicine, Hematology Department, Ankara, Turkey2 Ankara University School of Medicine, Hematology Department, Ankara, Turkey2 Ankara University School of Medicine, Hematology Department, Ankara, Turkey2 Ankara University School of Medicine, Hematology Department, Ankara, Turkeyhttp://journals.lww.com/10.1097/01.HS9.0000977304.57128.06
spellingShingle Derya Koyun
Güldane Cengiz Seval
Sinem Civrizbozdağ
Muhit Özcan
Pervin Topçuoğlu
PB2655: EVALUATION OF THE EFFICACY AND SAFETY IMMUNOSUPPRESSIVE THERAPY IN PATIENTS WITH ACQUIRED FACTOR VIII AND IX INHIBITOR
HemaSphere
title PB2655: EVALUATION OF THE EFFICACY AND SAFETY IMMUNOSUPPRESSIVE THERAPY IN PATIENTS WITH ACQUIRED FACTOR VIII AND IX INHIBITOR
title_full PB2655: EVALUATION OF THE EFFICACY AND SAFETY IMMUNOSUPPRESSIVE THERAPY IN PATIENTS WITH ACQUIRED FACTOR VIII AND IX INHIBITOR
title_fullStr PB2655: EVALUATION OF THE EFFICACY AND SAFETY IMMUNOSUPPRESSIVE THERAPY IN PATIENTS WITH ACQUIRED FACTOR VIII AND IX INHIBITOR
title_full_unstemmed PB2655: EVALUATION OF THE EFFICACY AND SAFETY IMMUNOSUPPRESSIVE THERAPY IN PATIENTS WITH ACQUIRED FACTOR VIII AND IX INHIBITOR
title_short PB2655: EVALUATION OF THE EFFICACY AND SAFETY IMMUNOSUPPRESSIVE THERAPY IN PATIENTS WITH ACQUIRED FACTOR VIII AND IX INHIBITOR
title_sort pb2655 evaluation of the efficacy and safety immunosuppressive therapy in patients with acquired factor viii and ix inhibitor
url http://journals.lww.com/10.1097/01.HS9.0000977304.57128.06
work_keys_str_mv AT deryakoyun pb2655evaluationoftheefficacyandsafetyimmunosuppressivetherapyinpatientswithacquiredfactorviiiandixinhibitor
AT guldanecengizseval pb2655evaluationoftheefficacyandsafetyimmunosuppressivetherapyinpatientswithacquiredfactorviiiandixinhibitor
AT sinemcivrizbozdag pb2655evaluationoftheefficacyandsafetyimmunosuppressivetherapyinpatientswithacquiredfactorviiiandixinhibitor
AT muhitozcan pb2655evaluationoftheefficacyandsafetyimmunosuppressivetherapyinpatientswithacquiredfactorviiiandixinhibitor
AT pervintopcuoglu pb2655evaluationoftheefficacyandsafetyimmunosuppressivetherapyinpatientswithacquiredfactorviiiandixinhibitor